INTRODUCTION

Furunculosis (boils) is a common skin disease caused by Staphylococcus aureus.
This infection is characterized by painful and deep infections of the hair follicle. Even mild lesions are very painful and often leave a scars. Many furunculosis strains acquired resistance to different antibiotics. Therefore, antibiotic treatment is frequently not effective, especially in patients who suffer from recurrent episodes (El- It has been observed that furunculosis most often spreads among family members. Direct contact with an infected person is a major risk factor for the development of furuncles. Other independent factors include diabetes, infection with HIV, alcoholism, anemia, previous antibiotic therapy, skin diseases (especially atopic dermatitis), previous hospitalization, the multiplicity of lesions, poor personal hygiene, deficiency of mannose binding lectin and impaired function of neutrophils 
Detection of slime production by light microscopy
Slime production of S. aureus isolates was evaluated by Congo red method with modification (crystal violet as a positive dye), according to the protocol of Korres et al. (2013) . Cultures S. aureus were incubated in trypticase soy broth (TSB) (Difco, USA) at 35±1°C for 24 h. After incubation, 2 drops of the bacterial suspension were mixed with 2 drops of crystal violet solution. Next, the mixture was smeared on a glass slide, washed with distilled water and air-dried. Slides were stained with Congo red solution (1 min) and air-dried. Afterwards, slides were examined with optical microscope (Olympus, Japan) and photographed. As positive result was indicated by appears a colourless halo around the bacterial cells against a pink background.
DNA isolation
Total DNA of S. aureus was isolated with a DNeasy Blood and Tissue Kit (Qiagen, Germany), according to the manufacturer's instructions. DNA was stored at 4 o C. 
Detection of S. aureus virulence factors by PCR
Essential oil analysis
CEO used in this study was obtained from Vera-Nord Company, Poland (commercial producer of plant essential oils and aromatic substances). The oil exhibited a strong and characteristic odor. It was intended to the production of cosmetics and household chemistry products. The analysis of CEO composition was performed by gas chromatography method with mass selective detector (GC-MS) using an Agilent 6890N gas chromatograph with a 5973N mass selective detector. The resolution of analytes was achieved using a HP-5MSI column (5% phenyl/95% dimethylpolysiloxane), 30 m x 0.25 mm I.D. and 0.25 μm film thickness. The column temperature was programmed as follows: initial temperature 60°C, ramp rate 8°C/min, final temperature 300°C (hold 5 min). Helium was used as carrier gas at a flow rate of 1.2 mL/min. The injector temperature was set at 250°C, MS quad: 150ºC; MS source: 230ºC. Mass spectra were obtained using electron impact ionization at 70 eV in full scan mode (mass range: 20-500 m/z). Before the analysis 100 μL of tested essential oil was dissolved in 1 mL of acetone (p.a.). The identification of the CEO components was based on the comparison of their mass spectra with the reference spectra from NIST 02 library. The relative contents of the particular compounds in essential oil were their peak area percentages in a total ion chromatogram.
Screening susceptibility of bacteria to antibiotics
The antimicrobial susceptibility of S. aureus isolates was performed in accordance with the European Committee on Antimicrobial Susceptibility Testing recommendations (EUCAST, 2013). Susceptibility to: ciprofloxacin -CIP (5 µg.disk -1 ), gentamycin -GE (10 µg.disk isolates. The plates were incubated at 35±1°C for 18±2 h and inhibition zones were measured. Strains resistant to FOX were considered as MRSA.
The D-test was performed with clindamycin -CC (2 µg.disk -1 ) and erythromycin -E (15 µg.disk -1 ) (Becton Dickinson, USA). These disks were placed 20 mm apart on the MHA plate seeded with the test strain. S. aureus strains resistant to CC and E were considered to have constitutive macrolides, lincosamides and streptogramins B resistance (cMLSB) phenotype. Moreover, strains with flattening of the susceptible zone of inhibition to CC adjacent to the E disk (Dshape) were considered to exhibit resistance inducible phenotype to macrolides, lincosamides and streptogramins B (iMLSB). Strains with circular zone around CC were considered to exhibit MSB phenotype (macrolides and streptogramins B resistance) (Saderi et al., 2011) .
Broth microdilution method -determination of the minimum inhibitory concentration (MIC)
The microdilution test was conducted in 96-well plates according to Urbaniak et al. (2014) with some modification. A dilution series of the CEO was obtained using 1% Tween 80 (Difco, USA) solution as the solvent. The final concentrations were 100-0.5 µL/mL. Each well received 100 µL of the specific concentrations of the CEO and TSB with addition 10% NaCl (Chempur, Poland) inoculated with 10 µL bacterial suspension (1.5x10 8 CFU/mL). The positive solvent control was completed with 100 µL of 1% Tween 80 solution. The final volume in each well was 110 µL. The microplates were covered with parafilm and incubated for 24 h at 35±1 o C. Inhibition of bacterial growth was confirmed by cultivation preincubated plates on Columbia agar with addition 5% sheep blood. The MIC values were defined by the lowest concentration of the CEO that inhibits the growth of the microorganism. The control wells solvent does not affect the growth of all tested bacterial strains. Each MIC test was conducted with three replicates.
RESULTS AND DISCUSSION
Chemical composition of the CEO
The results of qualitative and quantitative analysis of CEO purchased from VeraNord Company are shown in Table 1 . The main constituent of essential oil was cuminaldehyde (46.7%) followed by β-pinene (10.3%), durene (9.7%), γ-terpinene (8.9%) and limonene (4.7%). A total of 17 components were identified in the oil, accounting for 84.2% of the total oil (Table 1) (Table 1) . However, research conducted by Razzaghi-Abyaneh et al. (2009) showed that cuminaldehyde was present in essential oil extracted from C. carvi seeds. The caraway oil from Iran contained cuminaldehyde (22.08%) and γ-terpinene (17.86%) as its two main components, followed by p-cymene (7.99%).
Presence of slime
18 S. aureus strains were examined with Congo red method. The slime production of S. aureus was recorded in 12 (66.7%) isolates (Table 2) . On the microscopic slides, a spherical, Gram-positive cocci were surrounded by a welldefined halo on a pink background (Figure 1 ). Biofilm formation is important ability of bacteria and plays essential role in increased resistance to antimicrobial agents (Podbielska et al., 2010) . In addition, slime interferes with phagocytosis and enhances adhesion to host tissue and inanimate objects. According to Gündoğan et al. (2006) there is lack of correlation between antibiotic resistance and slime production among S. aureus observed. The results showed that not all of resistance strains produced an extracellular substances. In addition, we noticed that 6 susceptible strains also produced slime (Table 2 ). In our study S. aureus extracellular matrix did not affect on the MIC values. Both high and low concentration CEO did not impact on the presence of slime. It may indicate that slime did not play significant role in CEO attack on the bacteria surface. Figure 1 Microscopic views of slime formation of strain number 7 (x1,000 magnification, light microscopy) isolated from patient with furunculosis. Slimes (pointed with arrows) were visualized by double staining with crystal violet and Congo red.
Distribution of genes
In total, 80% (12/15) of the furunculosis strains were luk-PV positive and 13.3% (2/15) were mecA positive ( 
Susceptibility testing
2 MRSA (resistant to FOX) and 13 MSSA were isolated from furuncles. Of the all isolates, 46.7% (7/15) were resistant to at least one of the antibiotics tested. 46.7% (7/15) showed resistance to CC and E in disk diffusion testing. In D-test, 33.3% isolates exhibited cMLSB resistance and 13.3% had iMLSB resistance phenotype. MSB resistance phenotype as not detected. Details of the prevalence of antimicrobial resistance in tested isolates are shown in Table 2 aureus strain was isolated from the purulent lesions of the skin. Prevalence of cMLSB and iMLSB resistance phenotypes were 92.8% and 6.4%, respectively. This indicates that S. aureus strains with cMLSB phenotype were much more frequent than with iMLSB phenotype, which is similar to our results.
The activity of CEO against tested bacterial strains
Both control and all clinical strains derived from patients with furunculosis were sensitive to CEO ( Table 2 ). The inhibition of growth for all analyzed strains S. aureus after applying of CEO was observed. In the case of MSSA strains, the MIC values of essential oil were 26.7 ± 5.8 -66.7 ± 11.5 µL/mL, which was larger than that produced by the MIC values of control strains number 1 and 2 (both 10 ± 8.7 µL/mL). In the case of MRSA strains, the MIC values of CEO were 6.67 ± 2.9 -30 ± 10 µL/mL, which was also larger than that produced by the MIC values of control strain number 16 (11.7 ± 7.6 µL/mL). The largest number of isolates was inhibited by concentrations of 46.7 ± 5.8 µL/mL (4 antibiotic-susceptible strains and 1 cMLSB strain). In recent years, interest in essential oils is significantly observed. Essential oils are used in natural medicine to treat a wide range of infections caused by bacteria. Commercial essential oil was tested against S. aureus and demonstrated antibacterial activity against these strains ( . In these studies, GC-MS analysis of essential oil shown that the main components were carvone and limonene in contrast to our study. Moreover, tested by us CEO demonstrated higher MIC against S. aureus strains responsible for furunculosis than abovementioned results. 
CONCLUSION
There were no significant differences in MIC values depending on the susceptible/resistance to antibiotics, virulence genes and presence of slime. Commercial CEO has inhibitory effects on growth of S. aureus strains isolated from patients with furunculosis, regardless of the degree of resistance to antibiotics and virulence of the strain. CEO can be used as an alternative antibacterial agent in the treatment of furunculosis (especially in persons suffer from recurrent episodes).
